Delivery Order SPE2DB24D2003-SPE2DB25FXLL3
- Not listed
- The Defense Logistics Agency awarded a $10.7K firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely-used anticoagulant medication. The contract was awarded on July 31, 2025, with an ultimate completion date of August 1, 2025, and represents a non-set-aside, competitively awarded transaction. Performance will occur at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $15,235.54 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely used anticoagulant medication. This firm fixed-price delivery order, awarded on July 28, 2025, with a completion date of July 29, 2025, represents a non-competitive, non-set-aside procurement executed against an existing contract vehicle. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $8,405.86 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely prescribed anticoagulant medication. This competitive, firm fixed-price delivery order was issued on July 25, 2025, with an ultimate completion date of July 28, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating it was awarded through open...
- The Defense Logistics Agency awarded a delivery order valued at $2,705.60 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely used anticoagulant medication. The award, issued on July 24, 2025, with completion targeted for July 25, 2025, represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $33,966.52 for 60-count tablets of Eliquis 5 mg, a widely prescribed anticoagulant medication. Issued on July 28, 2025, with an ultimate completion date of July 29, 2025, this firm fixed-price delivery order represents a routine pharmaceutical procurement under a competitive award process with no set-aside designation. The product will be performed and delivered from AmerisourceBergen's corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,925.06 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely prescribed anticoagulant medication. The award was made on July 31, 2025, with an ultimate completion date of August 1, 2025, under a firm fixed-price contract type with no set-aside designation. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract...
- The Defense Logistics Agency awarded a $2,915.94 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely-prescribed anticoagulant medication. Issued on July 25, 2025, with an ultimate completion date of July 28, 2025, this firm fixed-price delivery order represents a non-set-aside, competitively awarded contract. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency awarded a delivery order valued at $15,877.85 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages) under a firm fixed-price contract. The award was made on July 31, 2025, with an ultimate completion date of August 1, 2025, and represents a non-set-aside, competitively awarded delivery order. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $13,065.95 for 60 tablets of Eliquis 5 mg, a widely prescribed anticoagulant medication. This competitive award, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, carries a firm fixed price structure with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this delivery order from...
- The Defense Logistics Agency awarded a delivery order valued at $7,162.15 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg on July 28, 2025, with an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Eliquis is an anticoagulant medication commonly prescribed for stroke prevention and blood clot treatment, indicating...
- SPE2DB24D2003Indefinite Delivery Contract
- SPE2DB24D2003-SPE2DB25FXLL3Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $11,516.50 to supply 60 tablets of Eliquis 5 mg, a widely-used anticoagulant medication. Issued on August 7, 2025, with an ultimate completion date of August 8, 2025, this firm fixed-price delivery order represents a routine pharmaceutical procurement within the federal medical supply chain. The contract carries no set-aside designation, indicating it was competitively awarded. Performance will be executed from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables the company to serve as a comprehensive pharmaceutical supplier to military healthcare systems and other federal health programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for military and veteran healthcare procurement, maintains an extensive portfolio of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains, positioning it to fulfill diverse federal medical supply requirements through the DLA's medical procurement infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.5k | 8/7/25 |